Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-01-19 @ 8:05 AM
Study NCT ID:
NCT05726292
Status:
RECRUITING
Last Update Posted:
2025-02-10
First Post:
2023-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Sponsor:
University of Chicago
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-02
First Submit QC Date:
None
Study First Post Date:
2023-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-05
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL